You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Norwegian cancer vaccine company has raised NOK 370 million and entered the Oslo Stock Exchange on Monday 3 June 2019. Several interested parties have now become shareholders in the company, totalling approximately 1 500 shareholders, reports Oslo Cancer Cluster. “It is good for the NorwAlready a subscriber Login You…
BioLamina with partners in the innovation milieu IndiCell receive funding to establish and propel individualized cell therapy treatments in Sweden. The funded project focuses on an autologous therapy model, in which skin cells are harvested from the patients themselves, then carefully reprogrammeAlready a subscriber Login You have read all your…
The funding model connects startup companies with investors and basic researchers with backers, reports Chris Tachibana. In 2012, the AssiStep, a handrail for people who need help with stairs, was just a clever student project. Last year, it hit the market. Norwegian University of Science and TecAlready a subscriber Login…
SAGA Diagnostics has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. The Series A2 round was led by Segulah Medical Acceleration and the Sciety investment syndicate with strong support from existing shareholders such as Hadean Ventures. "Already a subscriber Login You…
